Use of serotoninergic medications and cardiac valvulopathy: A nested case- control study in the Health Improvement Network (THIN) Database.

Aug-10

AUTHORS : Dr Annalisa Rubino (Details for study: Florence University), Astrazeneca, Cambridge, United Kingdom – Email: annalisa.rubino@astrazeneca.com OR Dr Francesco Lapi (details for study: Department of Preclinical and Clinical Pharmacology, University of Florence, Viale G. Pieraccini 6, 50139 Florence, Italy – Email: francesco.lapi@uniﬁ.it) is now at Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy – Email: lapi.francesco@simg.it

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 19(S1):102-103

DOI : 10.1002/pds.2019

Use of serotoninergic medications and cardiac valvulopathy: A nested case- control study in the Health Improvement Network (THIN) Database.

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study